0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Editorial |  ONLINE FIRST
Elizabeth C. Smyth, MB, BCh, MSc; Khurum Khan, MBBS; David Cunningham, FMedSci
JAMA Oncol. Published online February 11, 2016. doi:10.1001/jamaoncol.2015.6274

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Jenny F. Seligmann, PhD; Faye Elliott, MSc; Susan D. Richman, PhD; et al.
JAMA Oncol. Published online February 11, 2016. doi:10.1001/jamaoncol.2015.6065
Includes: Supplemental Content

JAMA Oncology | 
Viewpoint |  ONLINE FIRST
Scott D. Ramsey, MD, PhD; Gary H. Lyman, MD, MPH; Rick Bangs, MBA, PMP
JAMA Oncol. Published online February 11, 2016. doi:10.1001/jamaoncol.2015.5813

JAMA Oncology | 
Brief Report |  ONLINE FIRST
Elizabeth M. Swisher, MD; Maria I. Harrell, PhD; Barbara M. Norquist, MD; et al.
JAMA Oncol. Published online February 04, 2016. doi:10.1001/jamaoncol.2015.6053
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncol. Published online February 04, 2016. doi:10.1001/jamaoncol.2015.5932
Includes: Supplemental Content

JAMA Oncology | 
Review |  ONLINE FIRST
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.
JAMA Oncol. Published online February 04, 2016. doi:10.1001/jamaoncol.2015.5927

JAMA Internal Medicine | 
Research Letter |  ONLINE FIRST
Matthew V. Abola, BA; Vinay Prasad, MD, MPH
JAMA Intern Med. Published online February 01, 2016. doi:10.1001/jamainternmed.2015.7805

JAMA Dermatology | 
Viewpoint | 
William H. Eaglstein, MD
JAMA Dermatol. 2016;152(2):139-140. doi:10.1001/jamadermatol.2015.4903.

JAMA Ophthalmology | 
Original Investigation | 
John A. Wells, MD; Adam R. Glassman, MS; Lee M. Jampol, MD; et al.
JAMA Ophthalmol. 2016;134(2):127-134. doi:10.1001/jamaophthalmol.2015.4599.
Includes: Supplemental Content

JAMA Oncology | 
Research Letter | 
Jordan D. Lane, MD; Mark W. Friedberg, MD, MPP; Charles L. Bennett, MD, PhD, MPP
JAMA Oncol. 2016;2(2):274-276. doi:10.1001/jamaoncol.2015.3928.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Editorial  | 
AREG and EREG as Predictive Biomarkers for RAS Wild-Type Colorectal Cancer Treated With Panitumumab A Fresh Approach to an Old Puzzle
Elizabeth C. Smyth, MB, BCh, MSc; Khurum Khan, MBBS; David Cunningham, FMedSci
JAMA Oncology
Original Investigation  | 
Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer
Jenny F. Seligmann, PhD; Faye Elliott, MSc; Susan D. Richman, PhD; et al.
JAMA Oncology
Viewpoint  | 
Addressing Skyrocketing Cancer Drug Prices Comes With Tradeoffs Pick Your Poison
Scott D. Ramsey, MD, PhD; Gary H. Lyman, MD, MPH; Rick Bangs, MBA, PMP
JAMA Oncology
Brief Report  | 
Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma
Elizabeth M. Swisher, MD; Maria I. Harrell, PhD; Barbara M. Norquist, MD; et al.